IMMUNOTECH-B (06978) has announced that all conditions under the subscription agreement have been fulfilled or waived where applicable. New convertible bonds with a principal amount of RMB 270 million and notes with a principal amount of RMB 30 million have been issued to investors in accordance with their respective terms and conditions. As of the announcement date, the proceeds from the subscription will be used exclusively to fully and finally settle the principal amount of the 2023 convertible bonds, which are due on February 20, 2026.